1. Home
  2. INM

as of 12-12-2025 4:00pm EST

$1.43
+$0.04
+2.88%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Chart Type:
Time Range:
Founded: 1981 Country:
Canada
Canada
Employees: N/A City: VANCOUVER
Market Cap: 3.7M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 888.4K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.08 EPS Growth: N/A
52 Week Low/High: $1.13 - $8.27 Next Earning Date: 11-06-2025
Revenue: $4,798,116 Revenue Growth: -3.27%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered INM Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 70.27%
70.27%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest InMed Pharmaceuticals Inc. News

INM Breaking Stock News: Dive into INM Ticker-Specific Updates for Smart Investing

All INM News

Share on Social Networks: